Disartan

Amlodipine USP + Olmesartan Medoxomil BP

Composition : Disartan 5/20 : Amlodipine BP 5 mg + Olmesartan Medoxomil BP 20 mg Tablet &

Disartan 5/40 : Amlodipine BP 5 mg + Olmesartan Medoxomil BP 40 mg Tablet

Indication : This combination drug is indicated for the treatment of hypertension, alone or with other antihypertensive agents. This fixed combination drug is not indicated for the initial therapy of hypertension.

Dosage and administration : The usual starting dose of Disartan is 5/20mg once daily. The dosage can be increased after 1 to 2 weeks of therapy to a maximum dose of 10/40mg once daily as needed to control blood pressure. Maximum antihypertensive effects are attained within 2 weeks after a change in dose. Or, as directed by the registered physician.

Use in pregnancy and lactation : When used in pregnancy during the second and third trimesters, drugs that act directly on the rennin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, this drug should be discontinued as soon as possible.

Packing :

Disartan 5/20: 3x14's tablets in blister pack.

Disartan 5/40 : 2x14's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.